Compare EPSN & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EPSN | QSI |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.2M | 165.6M |
| IPO Year | 2018 | 2020 |
| Metric | EPSN | QSI |
|---|---|---|
| Price | $5.16 | $1.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.28 |
| AVG Volume (30 Days) | 56.9K | ★ 7.6M |
| Earning Date | 11-20-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.84% | N/A |
| EPS Growth | N/A | ★ 28.17 |
| EPS | ★ 0.26 | N/A |
| Revenue | N/A | ★ $2,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $406.32 |
| P/E Ratio | $19.88 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.20 | $0.69 |
| 52 Week High | $6.65 | $1.81 |
| Indicator | EPSN | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 26.68 | 52.63 |
| Support Level | N/A | $0.81 |
| Resistance Level | $6.01 | $1.73 |
| Average True Range (ATR) | 0.24 | 0.17 |
| MACD | -0.14 | -0.04 |
| Stochastic Oscillator | 1.84 | 36.99 |
Epsilon Energy Ltd is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering and production of natural gas and oil reserves. Its properties include Appalachian Basin-Pennsylvania, Permian Basin-Texas and New Mexico, Anadarko Basin-Oklahoma, Powder River Basin-Wyoming, Western Canadian Sedimentary Basin-Alberta, Canada. Its segments include The Upstream segment activities include acquisition, development and production of natural gas and oil reserves on properties within the United States and Canada; and The Gas Gathering segment partners with two other companies to operate a natural gas gathering system. The Upstream segment derives the majority of the revenue.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.